Pediatrix Medical Group, Inc. - Common Stock (MD)

CUSIP: 58502B106

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock
Shares outstanding
85,702,801
Total 13F shares
80,728,834
Share change
+60,470
Total reported value
$1,157,863,224
Put/Call ratio
0%
Price per share
$14.35
Number of holders
264
Value change
+$486,064
Number of buys
135
Number of sells
119

Security key

58502B106

Report period

Q2 2025

Institutions

264

Top holders

10

Top shareholders of MD - Pediatrix Medical Group, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F 13D/G
Company
15%
from 13D/G
14,026,480
$203,243,689 31 Mar 2025
Rubric Capital Management LP
13F 13D/G
Company
3.7%
from 13D/G
3,133,299
$45,401,503 31 Mar 2025
ALLIANCEBERNSTEIN L.P.
13F 13D/G
Company
2.2%
from 13D/G
6,852,691
$99,295,493 31 Mar 2025
VANGUARD GROUP INC
13F
Company
13%
10,796,650
$156,443,458 31 Mar 2025
13F
STATE STREET CORP
13F
Company
4.1%
3,526,084
$51,092,957 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
3.7%
3,170,537
$45,938,251 31 Mar 2025
13F
FMR LLC
13F
Company
3.4%
2,906,458
$42,114,576 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.4%
2,014,128
$29,192,047 31 Mar 2025
13F
Boston Partners
13F
Company
2.3%
1,981,889
$27,990,141 31 Mar 2025
13F
D. E. Shaw & Co., Inc.
13F
Company
2.2%
1,872,177
$27,127,845 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
1.8%
1,501,838
$21,761,643 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
1.5%
1,323,320
$19,174,913 31 Mar 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.4%
1,221,000
$17,692,290 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.3%
1,124,952
$16,300,554 31 Mar 2025
13F
Pacer Advisors, Inc.
13F
Company
1.2%
992,948
$14,387,817 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
1.1%
946,000
$13,707,539 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
1.1%
933,108
$13,520,735 31 Mar 2025
13F
Invesco Ltd.
13F
Company
1%
863,269
$12,508,768 31 Mar 2025
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.92%
791,201
$11,464,502 31 Mar 2025
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.92%
787,667
$11,413,295 31 Mar 2025
13F
Dana Investment Advisors, Inc.
13F
Company
0.9%
770,941
$11,170,935 31 Mar 2025
13F
SEGALL BRYANT & HAMILL, LLC
13F
Company
0.86%
734,786
$10,647,049 31 Mar 2025
13F
Qube Research & Technologies Ltd
13F
Company
0.84%
720,930
$10,446,276 31 Mar 2025
13F
BRANDES INVESTMENT PARTNERS, LP
13F
Company
0.81%
690,158
$10,000,390 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.71%
608,816
$8,821,744 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.69%
594,008
$8,607,176 31 Mar 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.68%
586,190
$8,493,894 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.66%
565,754
$8,197,776 31 Mar 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.65%
554,452
$8,034,009 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.65%
553,742
$8,023,722 31 Mar 2025
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.64%
545,600
$7,905,744 31 Mar 2025
13F
Aristotle Capital Boston, LLC
13F
Company
0.62%
530,178
$7,682,282 31 Mar 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.54%
458,880
$6,465,619 31 Mar 2025
13F
CastleKnight Management LP
13F
Company
0.48%
413,900
$5,997,411 31 Mar 2025
13F
Retirement System Of Texas Teacher
13F
Individual
0.43%
371,756
$5,386,745 31 Mar 2025
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.42%
356,982
$5,172,669 31 Mar 2025
13F
Empowered Funds, LLC
13F
Company
0.34%
289,452
$4,194,159 31 Mar 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.33%
280,440
$4,063,576 31 Mar 2025
13F
MARSHALL WACE, LLP
13F
Company
0.32%
271,736
$3,937,454 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.32%
270,287
$3,916,459 31 Mar 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.31%
268,506
$3,890,653 31 Mar 2025
13F
PUBLIC SECTOR PENSION INVESTMENT BOARD
13F
Company
0.31%
268,076
$3,884,421 31 Mar 2025
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.31%
264,060
$3,744,371 31 Mar 2025
13F
Trexquant Investment LP
13F
Company
0.31%
263,145
$3,812,971 31 Mar 2025
13F
NOMURA HOLDINGS INC
13F
Company
0.3%
260,456
$3,774,007 31 Mar 2025
13F
LSV ASSET MANAGEMENT
13F
Company
0.29%
248,000
$3,594,000 31 Mar 2025
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.28%
236,323
$3,424,320 31 Mar 2025
13F
Legal & General Group Plc
13F
Company
0.27%
233,588
$3,384,689 31 Mar 2025
13F
Russell Investments Group, Ltd.
13F
Company
0.26%
219,184
$3,175,975 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.25%
216,946
$3,143,529 31 Mar 2025
13F

Institutional Holders of Pediatrix Medical Group, Inc. - Common Stock (MD) as of Q2 2025

As of 30 Jun 2025, Pediatrix Medical Group, Inc. - Common Stock (MD) was held by 264 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 80,728,834 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, VICTORY CAPITAL MANAGEMENT INC, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, AMERICAN CENTURY COMPANIES INC, ALLIANCEBERNSTEIN L.P., and D. E. Shaw & Co., Inc.. This page lists 263 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
239
Q2 2025 holders
264
Holder diff
25
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .